About ocriplasmin
Vitreolytic enzyme
Used for
- Treats symptomatic vitreomacular adhesion, including when associated with a macular hole.
Usual adult dose
0.125 mg injected into the affected eye once by an ophthalmologist.
Common side effects
- Floaters
- Eye pain or discomfort
- Blurred or reduced vision
- Retinal tear or detachment
Important warnings
- Administered only by an eye specialist as an injection into the eye.
- May cause temporary vision changes, including flashes, floaters, or reduced vision.
- Serious complications include retinal detachment, retinal tear, and impaired retinal function.
- Avoid repeat treatment in the same eye; safety and effectiveness are not established.
Pregnancy
Human pregnancy data are limited; use only when potential benefit justifies potential risk.
Breastfeeding
It is unknown whether ocriplasmin passes into breast milk; effects on a nursing infant are unknown.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.